| Issue Date | Title | Author(s) |
| 2022-08 | Valproic acid counteracts polycyclic aromatic hydrocarbons (PAHs)-induced tumorigenic effects by regulating the polarization of macrophages. | Zhang, Y; Lim, D; Cai, Z; Peng, J; Jia, B; Chu, G; Zhang, F; Dong, C; Feng, Z |
| 2022-05 | Global Research Trends in Radiotherapy for Gliomas: A Systematic Bibliometric Analysis. | Zhang, Y; Lim, D; Yao, Y; Dong, C; Feng, Z |
| 2022-09-01 | Histone deacetylase inhibitor use as a radiosensitizer in solid organ malignancies: a systematic review protocol. | Sullivan, J; Feng, Z; Fahey, P; Agho, K; Hurley, S; Lim, D |
| 2022-01 | Histone deacetylase inhibitor 2-hexyl-4-pentynoic acid enhances hydroxyurea therapeutic effect in triple-negative breast cancer cells. | Ding, C; Su, B; Li, Q; Ding, W; Liu, G; Cai, Z; Zhang, F; Lim, D; Feng, Z |
| 2023 | Development of a risk model to predict prognosis in breast cancer based on cGAS-STING-related genes. | Chen, C; Wang, J; Dong, C; Lim, D; Feng, Z |
| 2023-06 | Global research trends in radiotherapy for breast cancer: a systematic bibliometric analysis. | Jia, B; Lim, D; Zhang, Y; Dong, C; Feng, Z |
| 2023-06 | HDAC inhibitor HPTA initiates anti-tumor response by CXCL9/10-recruited CXCR3+CD4+T cells against PAHs carcinogenicity. | Chen, C; Lim, D; Cai, Z; Zhang, F; Liu, G; Dong, C; Feng, Z |
| 2022-08 | Screen identifies fasudil as a radioprotector on human fibroblasts. | Yao, Y; Chen, C; Cai, Z; Liu, G; Ding, C; Lim, D; Chao, D; Feng, Z |
| 2023-10 | Hexyl-pentynoic acid serves as a novel radiosensitizer for breast cancer by inhibiting UCHL3-dependent Rad51 deubiquitination | Cai, Z; Lim, D; Jia, B; Liu, G; Ding, W; Wang, Z; Tian, Z; Peng, J; Zhang, F; Dong, C; Feng, Z |
| 2023-02-13 | VPA mediates bidirectional regulation of cell cycle progression through the PPP2R2A-Chk1 signaling axis in response to HU. | Su, B; Lim, D; Qi, C; Zhang, Z; Wang, J; Zhang, F; Dong, C; Feng, Z |
